DELRAY BEACH, Fla., July 14, 2025 /PRNewswire/ -- The global Respiratory Care Devices Market, valued at US$22.2 billion in 2024 stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. The advanced wound care market is primarily driven by several factors: the increasing geriatric population, the rising prevalence of chronic diseases, and a growing number of traumatic and burn injuries. These elements have significantly boosted the demand for effective wound management solutions. Furthermore, supportive government initiatives and reimbursement frameworks contribute to market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368
Browse in-depth TOC on "Respiratory Care Devices Market"
587 - Tables
63 - Figures
466 - Pages
By product type, Therapeutic devices are necessary for managing and treating the majority of acute and chronic respiratory diseases. They are required to provide patients with COPD, asthma, sleep apnea, and respiratory failure with life-sustaining respiratory therapy. The devices include high-flow nasal cannula systems, CPAP and BiPAP devices, nebulizers, ventilators, and oxygen concentrators. The therapeutic equipment market has increased manifold due to the need for long-term home-based respiratory therapy, the global burden of chronic disease, and the increase in hospitalization.
By disease indication, the respiratory care devices market is dominated by Chronic Obstructive Pulmonary Disease (COPD), which is increasingly becoming a global phenomenon, especially in the elderly population. This is due to higher demand for non-invasive ventilators, oxygen concentrators, nebulizers, and monitors. Since COPD is progressive and irreversible, it requires constant care and long-term respiratory therapy. The disease is also escalated by high-risk factors prevalent in developing and developed countries, including smoking, air pollution, and occupational exposures. Furthermore, since COPD is hospitalized and receives exacerbations, constant use of respiratory equipment at home and in the hospital is required.
By geography, the respiratory care devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa. The prevalence of chronic respiratory illnesses such as asthma, COPD, and sleep apnea is partly due to the aging population, extensive histories of smoking, and rising obesity. The strong healthcare infrastructure of the region and growing awareness of the significance of respiratory health enable early detection and treatment of such conditions. The COVID-19 pandemic also drove demand for oxygen therapy equipment and ventilators and hence created long-term interest and investment in respiratory care products. Large medical device firms, improved reimbursement policies, and quick adoption of new technology such as remote monitoring and telephonic integration of respiratory equipment have also driven the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=368
The key players in the global respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), Getinge (Sweden), Nihon Kohden Corporation (Japan), Hillrom & Welch Allyn (Baxter) (US), Teleflex Incorporated (Japan), Air Liquide (France), ICU Medical, Inc (US), AdaptHealth, LLC (US), Hamilton Medical (Switzerland), Medline Industries, LP (US), Allied Medical, LLC (US), Nonin (US), Apex Medical (Taiwan), Rotech Healthcare Inc. (US), Löwenstein Medical SE & Co. KG (Germany), WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc (Japan) and HUM GmbH (Germany).
Koninklijke Philips N.V. (Netherlands):
Koninklijke Philips N.V. is a global health technology leader known for its strong presence in the respiratory care devices market, particularly through its innovative, non-invasive ventilators, CPAP/BiPAP machines, and home oxygen therapy systems. With a strategic focus on integrated care, Philips combines medical devices with AI-powered digital platforms such as HealthSuite to deliver connected solutions across hospital and home settings. The company's core competencies lie in its robust R&D capabilities, global brand presence, and commitment to sustainability. Despite challenges from a global recall of certain respiratory devices, Philips continues to strengthen its position through new product launches. These efforts underline its leadership in delivering advanced, patient-centric respiratory care solutions globally.
Medtronic (Ireland)
Medtronic plc is one of the world's largest medical technology companies, operating in over 150+ countries. The company has merged its remaining Patient Monitoring and Respiratory Interventions segments into a unified business unit named Acute Care & Monitoring. Its core competencies include its strong presence in chronic disease management, cutting-edge patient monitoring systems, surgical innovations, and global supply chain capabilities. Known for its continuous investment in R&D and digital health integration, the company excels in developing minimally invasive therapies, advanced monitoring devices, and AI-powered diagnostics. Despite withdrawing from ventilator manufacturing, the company remains a major player in hospital-based care solutions, focusing on innovation in acute monitoring and intervention technologies. This restructuring reflects the aim to streamline operations, enhance profitability, and concentrate on higher-growth segments in critical and surgical care.
For more information, Inquire Now!
Related Reports:
Respiratory Diagnostics Market
Molecular Diagnostics Market
In Vitro Diagnostics Market
Point of Care Molecular Diagnostics Market
Infectious Disease Diagnostics Market
Get access to the latest updates on Respiratory Care Devices Companies and Respiratory Care Devices Market Size
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/respiratory-care-devices-market-worth-33-6-billion-by-2030-with-7-3-cagr--marketsandmarkets-302504094.html
